{{Rsnum
|rsid=237024
|Gene=TAB2
|Chromosome=6
|position=149400829
|Orientation=minus
|GMAF=0.3306
|Gene_s=SUMO4,TAB2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.0 | 0.0
| HCB | 7.0 | 23.3 | 69.8
| JPT | 10.3 | 33.3 | 56.4
| YRI | 0.0 | 1.6 | 98.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 7.0 | 23.3 | 69.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23042402
|Title=[Association between SUMO4 polymorphisms and coronary artery disease with and without type 2 diabetes mellitus]
}}

{{PMID Auto
|PMID=19122825
|Title=Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population.
|OA=1
}}

{{on chip | HumanOmni1Quad}}